Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 347

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis

Open access
Cho, Michael H, McDonald, Merry-Lynn N, Zhou, Xiaobo, Mattheisen, Manuel, Castaldi, Peter J, Hersh, Craig P, DeMeo, Dawn L, Sylvia, Jody S, Ziniti, John, Laird, Nan M, Lange, Christoph, Litonjua, Augusto A, Sparrow, David, Casaburi, Richard, Barr, R Graham, Regan, Elizabeth A, Make, Barry J, Hokanson, John E, Lutz, Sharon, Dudenkov, Tanda Murray, Farzadegan, Homayoon, Hetmanski, Jacqueline B, Tal-Singer, Ruth, Lomas, David A, Bakke, Per, Gulsvik, Amund, Crapo, James D, Silverman, Edwin K, Beaty, Terri H·2014·The Lancet Respiratory Medicine

Abstract

Background The genetic risk factors for susceptibility to chronic obstructive pulmonary disease (COPD) are still largely unknown. Additional genetic variants are likely to be identified by genome-wide association studies in larger cohorts or specific subgroups. Methods Genome-wide association analysis in COPDGene (non-Hispanic whites and African-Americans) was combined with existing data from the ECLIPSE, NETT/NAS, and GenKOLS (Norway) studies. Analyses were performed both using all moderate-to-severe cases and the subset of severe cases. Top loci not previously described as genome-wide significant were genotyped in the ICGN study, and results combined in a joint meta-analysis. Findings Analysis of a total of 6,633 moderate-to-severe cases and 5,704 controls confirmed association at three known loci: CHRNA3/CHRNA5/IREB2, FAM13A, and HHIP (10−12 < P < 10−14), and also showed significant evidence of association at a novel locus near RIN3 (overall P, including ICGN = 5•4×10−9). In the severe COPD analysis (n=3,497), the effects at two of three previously described loci were significantly stronger; we also identified two additional loci previously reported to affect gene expression of MMP12 and TGFB2 (overall P = 2•6x10−9 and 8•3×10−9). RIN3 and TGFB2 expression levels were reduced in a set of Lung Tissue Research Consortium COPD lung tissue samples compared with controls. Interpretation In a genome-wide study of COPD, we confirmed associations at three known loci and found additional genome-wide significant associations with moderate-to-severe COPD near RIN3 and with severe COPD near MMP12 and TGFB2. Genetic variants, apart from alpha-1 antitrypsin deficiency, increase the risk of COPD. Our analysis of severe COPD suggests additional genetic variants may be identified by focusing on this subgroup. Funding National Heart, Lung, and Blood Institute; the COPD Foundation through contributions from AstraZeneca, Boehringer Ingelheim, Novartis, and Sepracor; GlaxoSmithKline; Centers for Medicare and Medicaid Services; Agency for Healthcare Research and Quality; US Department of Veterans Affairs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2213-2600(14)70002-5

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 347

Metadata

Authors
Cho, M. H., McDonald, M.-L. N., Zhou, X., Mattheisen, M., Castaldi, P. J., Hersh, C. P., DeMeo, D. L., Sylvia, J. S., Ziniti, J., Laird, N. M., Lange, C., Litonjua, A. A., Sparrow, D., Casaburi, R., Barr, R. G., Regan, E. A., Make, B. J., Hokanson, J. E., Lutz, S., Dudenkov, T. M., Farzadegan, H., Hetmanski, J. B., Tal-Singer, R., Lomas, D. A., Bakke, P., Gulsvik, A., Crapo, J. D., Silverman, E. K., & Beaty, T. H.
Venue
The Lancet Respiratory Medicine
Publisher
Elsevier BV
Published
2014-03
Volume
2
Issue
3
Pages
214-225
ISSN
2213-2600 (ISSN-L)
OpenAlex
W2005623173
Cited by
347
References
18
FWCI
27.14
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis. https://app.cochat.ai/papers/10.1016/s2213-2600(14)70002-5
The paper
Cho, M. H., McDonald, M.-L. N., Zhou, X., Mattheisen, M., Castaldi, P. J., Hersh, C. P., DeMeo, D. L., Sylvia, J. S., Ziniti, J., Laird, N. M., Lange, C., Litonjua, A. A., Sparrow, D., Casaburi, R., Barr, R. G., Regan, E. A., Make, B. J., Hokanson, J. E., Lutz, S., . . . Beaty, T. H. (2014). Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis. The Lancet Respiratory Medicine. https://doi.org/10.1016/s2213-2600(14)70002-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.